Publication Name	World Journal of Hepatology
Manuscript ID	64928
Country	Poland

Received	2021-02-25 21:30
Peer-Review Started	2021-02-25 21:44
To Make the First Decision
Return for Revision	2021-05-03 00:18
Revised	2021-05-07 07:50
Second Decision	2021-11-22 03:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-11-25 02:28
Articles in Press	2021-11-25 02:28
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-12-21 04:08
Publish the Manuscript Online	2021-12-27 05:24

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Liver function in COVID-19 infection
Manuscript Source	Invited Manuscript
All Author List	Dagmara Przekop, Ewa Gruszewska and Lech Chrostek
ORCID	Author(s) ORCID Number Dagmara Przekop http://orcid.org/0000-0002-8001-8133 Ewa Gruszewska http://orcid.org/0000-0002-7702-5148 Lech Chrostek http://orcid.org/0000-0001-6701-1861
Funding Agency and Grant Number
Corresponding Author	Lech Chrostek, MD, PhD, Full Professor, Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A, Bialystok 15-269, Poland. chrostek@umb.edu.pl
Key Words	COVID-19; Pathogenesis of liver injury; Angiotensin-converting enzyme 2 receptor; Liver function tests; Severe COVID-19; Treatment effect
Core Tip	The frequency of abnormalities in liver function tests (LFTs) in coronavirus disease 2019 (COVID-19) infected patients increases with age and is observed in males more than females. A pre-existing history of liver disease and comorbidity increases LFT abnormality and the likelihood of severe liver damage in COVID-19 infection. Antiviral treatment and treatment of comorbid diseases intensifies the hepatotoxic effect on the liver, which often manifests itself in higher levels in LFTs.
Publish Date	2021-12-27 05:24
Citation	Przekop D, Gruszewska E, Chrostek L. Liver function in COVID-19 infection. World J Hepatol 2021; 13(12): 1909-1918
URL	https://www.wjgnet.com/1948-5182/full/v13/i12/1909.htm
DOI	https://dx.doi.org/10.4254/wjh.v13.i12.1909

Full Article (PDF)	WJH-13-1909.pdf
Full Article (Word)	WJH-13-1909.docx
Manuscript File	64928_Auto_Edited-A.docx
Answering Reviewers	64928-Answering reviewers.pdf
Audio Core Tip	64928-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	64928-Conflict-of-interest statement.pdf
Copyright License Agreement	64928-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	64928-Language certificate.pdf
Peer-review Report	64928-Peer-review(s).pdf
Scientific Misconduct Check	64928-Liu M-2.png
Scientific Editor Work List	64928-Scientific editor work list.pdf
CrossCheck Report	64928-CrossCheck report.pdf